대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제5장 갑상선분화암의 수술 후 초기 질병 상태와 재발위험도 평가 및 초기위험군 분류 2024
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이은경 | - |
dc.contributor.author | 송영신 | - |
dc.contributor.author | 강호철 | - |
dc.contributor.author | 김선욱 | - |
dc.contributor.author | 나동규 | - |
dc.contributor.author | 문신제 | - |
dc.contributor.author | 임동준 | - |
dc.contributor.author | 정경연 | - |
dc.contributor.author | 정윤재 | - |
dc.contributor.author | 정찬권 | - |
dc.contributor.author | 박영주 | - |
dc.date.accessioned | 2024-07-15T01:00:24Z | - |
dc.date.available | 2024-07-15T01:00:24Z | - |
dc.date.issued | 2024-05 | - |
dc.identifier.issn | 2384-3799 | - |
dc.identifier.issn | 2466-1899 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74744 | - |
dc.description.abstract | The American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) staging classification of thyroid cancer can predict death but cannot determine the type and frequency of follow-up testing. Risk stratification is a concept proposed by the American Thyroid Association that uses additional prognostic factors that are not included in the AJCC/UICC classification, such as number or size of metastatic lymph nodes, genetic mutations, and vascular invasion in follicular cancer, to further refine the prognosis of thyroid cancer. The risk of recurrence was categorized as low, intermediate, and high risk, and the need for total thyroidectomy, radioiodine therapy, or thyroid-stimulating hormone suppression was determined depending on each risk level. This approach has been accepted worldwide, and the previous recommendations of the Korean Thyroid Association followed a similar line of thinking but these have been modified in the revised 2024 guidelines. For the revised initial risk stratification, after careful review of the results of the recent meta-analyses and large observational studies and after a multidisciplinary meeting, four major changes were made: 1) thyroid cancer was reclassified according to the World Health Organization (WHO) 2022 tumor classification system; 2) recurrence risk was stratified by combining encapsulated follicular variant papillary thyroid cancer, follicular thyroid cancer, and oncocytic thyroid cancer, which have similar recurrence risk and associated factors, into follicular-patterned tumor; 3) low-risk groups were defined as those with a known recurrence rate of ≤5%, high-risk groups were upgraded to those with a known recurrence rate of ≥30%, and intermediate-risk groups were those with a recurrence risk of 5–30%; and 4) the intermediate risk group had the recurrence rate presented according to various clinicopathological factors, mainly based on reports from Korea. Thus, it is recommended to evaluate the initial risk group by predicting the recurrence rate by combining each clinical factor in individual patients, rather than applying the recurrence rate caused by single risk factor. | - |
dc.format.extent | 29 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한갑상선학회 | - |
dc.title | 대한갑상선학회 갑상선분화암 진료권고안; Part I. 갑상선분화암의 초기치료 - 제5장 갑상선분화암의 수술 후 초기 질병 상태와 재발위험도 평가 및 초기위험군 분류 2024 | - |
dc.title.alternative | Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 5. Evaluation of Recurrence Risk Postoperatively and Initial Risk Stratification in Differentiated Thyroid Cancer 2024 | - |
dc.type | Article | - |
dc.identifier.doi | 10.11106/ijt.2024.17.1.68 | - |
dc.identifier.bibliographicCitation | International Journal of Thyroidology, v.17, no.1, pp 68 - 96 | - |
dc.identifier.kciid | ART003086070 | - |
dc.description.isOpenAccess | Y | - |
dc.citation.endPage | 96 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 68 | - |
dc.citation.title | International Journal of Thyroidology | - |
dc.citation.volume | 17 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | 갑상선분화암 | - |
dc.subject.keywordAuthor | 위험도 평가 | - |
dc.subject.keywordAuthor | 예후 | - |
dc.subject.keywordAuthor | 재발 | - |
dc.subject.keywordAuthor | 진료권고안 | - |
dc.subject.keywordAuthor | 대한갑상선학회 | - |
dc.subject.keywordAuthor | Differentiated thyroid cancer | - |
dc.subject.keywordAuthor | Risk assessment | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Guideline | - |
dc.subject.keywordAuthor | Korean Thyroid Association | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.